Detalles de la búsqueda
1.
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
Lancet Oncol
; 25(1): 29-45, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101433
2.
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.
Lancet Oncol
; 25(1): 46-61, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101431
3.
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
Lancet
; 395(10236): 1547-1557, 2020 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32416780
4.
Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer.
Cancers (Basel)
; 15(13)2023 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444507
5.
Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma.
Eur Urol Open Sci
; 58: 28-36, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37954037
6.
Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : An initiative of the Central European Cooperative Oncology Group (CECOG).
Wien Klin Wochenschr
; 134(19-20): 697-704, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35312859
7.
Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice.
Radiol Oncol
; 55(4): 491-498, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939898
8.
Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer - results from a real-world setting.
Cancer Treat Res Commun
; 25: 100201, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979704
Resultados
1 -
8
de 8
1
Próxima >
>>